ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF

    公开(公告)号:US20210246204A1

    公开(公告)日:2021-08-12

    申请号:US16972840

    申请日:2019-06-07

    Applicant: Alector LLC

    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Patent Agency Ranking